000 01427 a2200409 4500
005 20250517170855.0
264 0 _c20180521
008 201805s 0 0 eng d
022 _a1532-2777
024 7 _a10.1016/j.mehy.2017.06.029
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChanda, Warren
245 0 0 _aThe potential management of oral candidiasis using anti-biofilm therapies.
_h[electronic resource]
260 _bMedical hypotheses
_cSep 2017
300 _a15-18 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntifungal Agents
_xtherapeutic use
650 0 4 _aBiofilms
_xdrug effects
650 0 4 _aCandida albicans
_xdrug effects
650 0 4 _aCandidiasis, Oral
_ximmunology
650 0 4 _aHost-Pathogen Interactions
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunoglobulin A
_xbiosynthesis
650 0 4 _aLactoferrin
_xtherapeutic use
650 0 4 _aMicrobiota
_xdrug effects
650 0 4 _aModels, Biological
650 0 4 _aPhotochemotherapy
650 0 4 _aProbiotics
_xtherapeutic use
650 0 4 _aSaliva
_ximmunology
650 0 4 _aStreptococcus mutans
_xgrowth & development
700 1 _aJoseph, Thomson P
700 1 _aWang, Wendong
700 1 _aPadhiar, Arshad A
700 1 _aZhong, Mintao
773 0 _tMedical hypotheses
_gvol. 106
_gp. 15-18
856 4 0 _uhttps://doi.org/10.1016/j.mehy.2017.06.029
_zAvailable from publisher's website
999 _c27475473
_d27475473